Data for: Adherence to antihypertensive medication in severely hypertensive patients after referral to secondary health care: a prospective cohort study

Nonadherence (NAd) to antihypertensive medication is associated with a lack of blood pressure control and worsened long-term outcomes. Increased access to a program for high-risk cardiovascular patients has the potential to reduce NAd and improve clinical outcomes.
We prospectively collected data of severely hypertensive patients at the entry and after 12-month-long access to secondary healthcare center located in a Southern Brazilian city. We evaluated implementation NAd prevalence and risk factors based on Bronfenbrenner's multilevel ecological model. The Morisky Green Levine Scale (MGLS) was used to analyze antihypertensive medication NAd. The cohort was composed of 485 patients. Demographic and clinical data were collected at the entry of the secondary health care program. Adherence status, blood pressure, antihypertensive drug therapy were assessed at entry and after a 12-month follow-up. Approval of the health care program was collected after a 12-month follow-up.

降压药物服药不依从性（Nonadherence, NAd）与血压控制不佳及远期不良预后密切相关。为高危心血管疾病患者提供更便捷的项目服务，有望降低服药不依从性并改善临床结局。
本研究前瞻性收集了巴西南部某城市二级医疗中心的重症高血压患者入组基线及接受12个月诊疗后的相关数据。基于布朗芬布伦纳（Bronfenbrenner）多层次生态模型，本研究评估了项目实施过程中服药不依从性的流行率及其危险因素。本研究采用莫里斯基-格林莱文量表（Morisky Green Levine Scale, MGLS）分析降压药物服药不依从性情况。
本研究队列共纳入485例患者。研究人员在患者入组二级医疗项目时收集了其人口学特征与临床相关数据。分别于入组时及12个月随访后，对患者的服药依从性状态、血压水平及降压药物治疗方案进行评估。本研究于12个月随访后收集了该医疗项目的审批相关文件。